CD8A and colorectal carcinoma: Furthermore, the scRNA-seq analysis of 37,931 T cells from 16 CRC patients suggests the phenotypically and functionally distinguishable CD4+ and CD8+ effector T cell types are associated with clinical outcomes (Masuda et al., 2022).